Atlas Trials

Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia

Clinical trial NCT07680803 · RECRUITING

Trial details

NCT number
NCT07680803
Sponsor
Fondazione Telethon
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Transfusion-dependent Beta-Thalassemia
Start date
2026-07-06
Primary completion
2028-10-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.